2025
SJR Q1
JCR Q2 · 3,6
OA
68 matched articles
SCIE
Journal detail
Orphanet Journal of Rare Diseases
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
17501172
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,218
- Quartile Q1
- H-Index 150
- Cites/doc 3,51
- Docs (3y) 1.304
- Cites (3y) 5.216
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,6
- 5Y JIF 4,2
- JCI 0,79
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Genetics (clinical) Q2
- Medicine (miscellaneous) Q1
- Pharmacology (medical) Q1
Areas
- Medicine
WoS categories
- Genetics & Heredity | Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,218 | 3,6 | 4,2 | 0,79 | Q2 | 150 |
| 2024 | Q1 | Q2 | 1,269 | 3,5 | 4 | 0,84 | Q2 | 143 |
| 2023 | Q1 | Q2 | 1,182 | 3,4 | 3,9 | 0,82 | Q2 | 143 |
| 2022 | Q1 | Q2 | 1,12 | 3,7 | 4,4 | 0,83 | Q2 | 143 |
| 2021 | Q1 | Q2 | 1,105 | 4,3 | 5 | 0,83 | Q2 | 143 |
| 2020 | Q1 | Q2 | 1,274 | 4,1 | 4,8 | 0,92 | Q2 | 143 |
| 2019 | Q1 | Q2 | 1,275 | 3,5 | 4 | 0,97 | Q2 | 143 |
| 2018 | — | Q2 | — | 3,7 | 4,3 | 1,11 | Q1 | — |
| 2017 | Q1 | Q2 | 1,413 | 3,6 | 4,2 | 1,01 | Q2 | 143 |
| 2016 | Q1 | Q2 | 1,57 | 3,5 | 4,2 | — | — | 143 |
| 2015 | Q1 | Q2 | 1,522 | 3,3 | 4,1 | — | — | 143 |
| 2014 | Q1 | Q2 | 1,768 | 3,4 | 4,4 | — | — | 143 |
| 2013 | Q1 | Q1 | 1,895 | 4 | 5,4 | — | — | 143 |
| 2012 | Q1 | Q1 | 1,97 | 4,3 | 5,7 | — | — | 143 |
| 2011 | Q1 | Q1 | 2,181 | 5,1 | 6 | — | — | 143 |
| 2010 | Q1 | Q1 | 2,29 | 5,9 | 6 | — | — | 143 |
| 2009 | — | Q1 | — | 5,8 | 5,1 | — | — | — |
| 2008 | — | Q2 | — | 3,1 | 3,1 | — | — | — |
| 2007 | — | Q3 | — | 1,3 | 1,3 | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 61/192 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 79/191 |
| 2024 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 61/192 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 68/195 |
| 2023 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 63/191 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 76/189 |
| 2022 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 60/171 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 75/136 |
| 2021 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 61/175 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 68/139 |
| 2020 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 65/176 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 67/140 |
| 2019 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 59/178 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 58/139 |
| 2018 | GENETICS & HEREDITY | SCIE | Q2 | Q1 | 48/174 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 48/136 |
| 2017 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 55/171 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 45/133 |
| 2016 | GENETICS & HEREDITY | SCIE | Q2 | — | 59/167 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 35/128 |
| 2015 | GENETICS & HEREDITY | SCIE | Q2 | — | 57/166 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 37/124 |
| 2014 | GENETICS & HEREDITY | SCIE | Q2 | — | 56/167 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 37/123 |
| 2013 | GENETICS & HEREDITY | SCIE | Q2 | — | 43/165 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 25/124 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 26/121 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 14/112 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 10/106 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 7/93 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 22/83 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 59/81 |